Elbit Imaging Ltd
Elbit Imaging Ltd. does not have significant operations. Previously, it was engaged in development and sale of medical systems. The company was formerly known as Elbit Medical Imaging Ltd. and changed its name to Elbit Imaging Ltd. in November 2007. Elbit Imaging Ltd. was incorporated in 1996 and is headquartered in Bnei Brak, Israel.
Elbit Imaging Ltd (EMITF) - Net Assets
Latest net assets as of December 2024: $68.36 Million USD
Based on the latest financial reports, Elbit Imaging Ltd (EMITF) has net assets worth $68.36 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($72.06 Million) and total liabilities ($3.70 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $68.36 Million |
| % of Total Assets | 94.86% |
| Annual Growth Rate | -8.75% |
| 5-Year Change | -27.63% |
| 10-Year Change | -77.52% |
| Growth Volatility | 90.69 |
Elbit Imaging Ltd - Net Assets Trend (1996–2024)
This chart illustrates how Elbit Imaging Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Elbit Imaging Ltd (1996–2024)
The table below shows the annual net assets of Elbit Imaging Ltd from 1996 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $68.36 Million | +9.06% |
| 2023-12-31 | $62.67 Million | +0.02% |
| 2022-12-31 | $62.66 Million | -11.64% |
| 2021-12-31 | $70.92 Million | -24.91% |
| 2020-12-31 | $94.45 Million | +155.81% |
| 2019-12-31 | $-169.24 Million | -181.46% |
| 2018-12-31 | $-60.13 Million | +59.59% |
| 2017-12-31 | $-148.78 Million | -406.05% |
| 2016-12-31 | $48.61 Million | -84.01% |
| 2015-12-31 | $304.06 Million | -57.37% |
| 2014-12-31 | $713.24 Million | +274.54% |
| 2013-12-31 | $-408.63 Million | -128.75% |
| 2012-12-31 | $1.42 Billion | -7.65% |
| 2011-12-31 | $1.54 Billion | -29.33% |
| 2010-12-31 | $2.18 Billion | +1.98% |
| 2009-12-31 | $2.14 Billion | -12.41% |
| 2008-12-31 | $2.44 Billion | -24.70% |
| 2007-12-31 | $3.24 Billion | +45.47% |
| 2006-12-31 | $2.23 Billion | +108.73% |
| 2005-12-31 | $1.07 Billion | -13.81% |
| 2004-12-31 | $1.24 Billion | -12.86% |
| 2003-12-31 | $1.42 Billion | -10.17% |
| 2002-12-31 | $1.58 Billion | +17.21% |
| 2001-12-31 | $1.35 Billion | +16.03% |
| 2000-12-31 | $1.16 Billion | -9.24% |
| 1999-12-31 | $1.28 Billion | -9.15% |
| 1998-12-31 | $1.41 Billion | +48.33% |
| 1997-12-31 | $950.04 Million | +7.07% |
| 1996-12-31 | $887.32 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Elbit Imaging Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 103.8% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $71.87 Million | 105.13% |
| Other Components | $10.52 Million | 15.39% |
| Total Equity | $68.36 Million | 100.00% |
Elbit Imaging Ltd Competitors by Market Cap
The table below lists competitors of Elbit Imaging Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bicycle Therapeutics Ltd
NASDAQ:BCYC
|
$8.86 Million |
|
Biocardia Inc
NASDAQ:BCDA
|
$8.86 Million |
|
GSD Technologies Co. Ltd
TW:6641
|
$8.86 Million |
|
Nordic Iron Ore
ST:NIO
|
$8.86 Million |
|
I-Scream Edu Co.Ltd
KQ:289010
|
$8.85 Million |
|
Dala Energi AB
ST:DE
|
$8.85 Million |
|
NFL Biosciences SAS
PA:ALNFL
|
$8.85 Million |
|
PPK Group Ltd
AU:PPK
|
$8.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Elbit Imaging Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 62,674,000 to 68,363,000, a change of 5,689,000 (9.1%).
- Net loss of 5,327,000 reduced equity.
- New share issuances of 356,000 increased equity.
- Other comprehensive income increased equity by 173,507,000.
- Other factors decreased equity by 162,847,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.33 Million | -7.79% |
| Share Issuances | $356.00K | +0.52% |
| Other Comprehensive Income | $173.51 Million | +253.8% |
| Other Changes | $-162.85 Million | -238.21% |
| Total Change | $- | 9.08% |
Book Value vs Market Value Analysis
This analysis compares Elbit Imaging Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.21x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.00x to 0.21x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-12-31 | $1679.38 | $1.35 | x |
| 1997-12-31 | $1755.10 | $1.35 | x |
| 1998-12-31 | $2640.94 | $1.35 | x |
| 1999-12-31 | $2230.13 | $1.35 | x |
| 2000-12-31 | $2074.61 | $1.35 | x |
| 2001-12-31 | $2286.75 | $1.35 | x |
| 2002-12-31 | $2754.48 | $1.35 | x |
| 2003-12-31 | $2543.30 | $1.35 | x |
| 2004-12-31 | $2069.55 | $1.35 | x |
| 2005-12-31 | $2867.40 | $1.35 | x |
| 2006-12-31 | $3463.63 | $1.35 | x |
| 2007-12-31 | $4724.21 | $1.35 | x |
| 2008-12-31 | $3235.51 | $1.35 | x |
| 2009-12-31 | $2216.22 | $1.35 | x |
| 2010-12-31 | $1773.50 | $1.35 | x |
| 2011-12-31 | $867.17 | $1.35 | x |
| 2012-12-31 | $746.48 | $1.35 | x |
| 2013-12-31 | $-2488.50 | $1.35 | x |
| 2014-12-31 | $29.31 | $1.35 | x |
| 2015-12-31 | $2.10 | $1.35 | x |
| 2016-12-31 | $-9.63 | $1.35 | x |
| 2017-12-31 | $-21.15 | $1.35 | x |
| 2018-12-31 | $-4.32 | $1.35 | x |
| 2019-12-31 | $-13.21 | $1.35 | x |
| 2020-12-31 | $10.28 | $1.35 | x |
| 2021-12-31 | $7.74 | $1.35 | x |
| 2022-12-31 | $6.85 | $1.35 | x |
| 2023-12-31 | $6.43 | $1.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Elbit Imaging Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.79%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.05x
- Recent ROE (-7.79%) is above the historical average (-23.82%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | 4.35% | 1.54% | 0.98x | 2.87x | $-34.11 Million |
| 1997 | 2.61% | 0.97% | 0.91x | 2.93x | $-48.17 Million |
| 1998 | 40.93% | 96100.00% | 0.00x | 2.68x | $302.14 Million |
| 1999 | -5.83% | -14.32% | 0.12x | 3.46x | $-130.29 Million |
| 2000 | -2.03% | -2.88% | 0.15x | 4.76x | $-86.54 Million |
| 2001 | 11.54% | 15.68% | 0.14x | 5.16x | $13.49 Million |
| 2002 | 3.81% | 8.28% | 0.09x | 5.40x | $-67.10 Million |
| 2003 | -11.75% | -20.39% | 0.10x | 5.80x | $-206.58 Million |
| 2004 | 5.39% | 7.38% | 0.13x | 5.62x | $-37.12 Million |
| 2005 | 8.24% | 10.64% | 0.22x | 3.59x | $-18.59 Million |
| 2006 | 35.03% | 33.59% | 0.27x | 3.85x | $399.78 Million |
| 2007 | 45.18% | 26.29% | 0.41x | 4.15x | $717.88 Million |
| 2008 | -7.55% | -9.44% | 0.13x | 6.33x | $-241.08 Million |
| 2009 | -56.70% | -76.91% | 0.07x | 9.96x | $-627.32 Million |
| 2010 | 8.15% | 4.21% | 0.14x | 14.07x | $-14.08 Million |
| 2011 | -73.66% | -26.20% | 0.10x | 28.84x | $-300.88 Million |
| 2012 | -94.83% | -43.75% | 0.09x | 22.91x | $-324.55 Million |
| 2013 | 0.00% | -320.48% | 0.08x | 0.00x | $-1.05 Billion |
| 2014 | 434.95% | 253.15% | 0.11x | 15.78x | $985.80 Million |
| 2015 | -965.16% | -53.50% | 0.13x | 140.17x | $-188.08 Million |
| 2016 | 0.00% | -74.40% | 0.12x | 0.00x | $-185.98 Million |
| 2017 | 0.00% | -43.18% | 0.77x | 0.00x | $-318.59 Million |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-513.86 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-95.36 Million |
| 2020 | -7.28% | 0.00% | 0.00x | 1.08x | $-16.32 Million |
| 2021 | -28.90% | 0.00% | 0.00x | 1.02x | $-27.59 Million |
| 2022 | -0.50% | 0.00% | 0.00x | 1.02x | $-6.58 Million |
| 2023 | -28.95% | -5531.40% | 0.01x | 1.02x | $-24.41 Million |
| 2024 | -7.79% | 0.00% | 0.00x | 1.05x | $-12.16 Million |
Industry Comparison
This section compares Elbit Imaging Ltd's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $-56,363,212
- Average return on equity (ROE) among peers: -7.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Elbit Imaging Ltd (EMITF) | $68.36 Million | 4.35% | 0.05x | $8.86 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $-22.04K | 0.00% | 0.00x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $5.32 Million | -71.85% | 3.84x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $-185.37K | 0.00% | 0.00x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-181.19K | 0.00% | 0.00x | $14.73K |
| ACRO Biomedical Co Ltd (ACBM) | $-14.79K | 0.00% | 0.00x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-1.02K | 0.00% | 0.00x | $3.15K |